Scilex Holding (SCLX) Current Leases (2021 - 2026)
Scilex Holding (SCLX) posted quarterly Current Leases of $1.7 million for Q1 2026, up 132.84% year-over-year from $740000.0 in Q1 2025, and down 0.58% quarter-over-quarter from $1.7 million in Q4 2025.
Scilex Holding (SCLX) Current Leases (2021 - 2026) Analysis & Trends
Scilex Holding's Current Leases history runs 6 years deep, the most recent figure standing at $1.7 million for Q1 2026.
- In Q1 2026, Current Leases rose 132.84% year-over-year to $1.7 million; the TTM figure through Mar 2026 stood at $1.7 million (up 132.84% YoY), while the FY2025 annual figure was $1.7 million, up 142.72% from the prior year.
- Current Leases for Q1 2026 stood at $1.7 million, down from $1.7 million in the prior quarter.
- The five-year high for Current Leases was $1.7 million in Q4 2025, with the low at $688000.0 in Q3 2024.
- The 5-year median for Current Leases is $763500.0 (2023), against an average of $888142.9.
- The sharpest annual moves came in 2024 and 2025: Current Leases fell 12.58% in 2024, then soared 142.72% in 2025.
- Scilex Holding's Current Leases stood at $745000.0 in 2022, then climbed by 1.88% to $759000.0 in 2023, then fell by 5.93% to $714000.0 in 2024, then surged by 142.72% to $1.7 million in 2025, then dropped by 0.58% to $1.7 million in 2026.
- Business Quant data shows SCLX's Current Leases at $1.7 million in Q1 2026, $1.7 million in Q4 2025, and $796000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 653.63 Bn | 632.88 Bn | 17.26 Bn | - |
| 2 | AbbVie | 471.61 Bn | 465.04 Bn | 12.70 Bn | - |
| 3 | Merck | 380.82 Bn | 373.68 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 303.41 Bn | 295.72 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 258.06 Bn | 253.16 Bn | 12.86 Bn | - |
| 6 | Amgen | 237.46 Bn | 223.47 Bn | 7.24 Bn | - |
| 7 | Gilead Sciences | 183.34 Bn | 180.16 Bn | 6.22 Bn | - |
| 8 | Pfizer | 161.82 Bn | 150.12 Bn | 10.94 Bn | - |
| 9 | Gsk | 105.95 Bn | 101.79 Bn | 8.24 Bn | - |
| 10 | Scilex Holding | 39.18 Mn | -73.61 Mn | 3.97 Mn | 2.24 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.72 Mn |
| Dec 31, 2025 | 1.73 Mn |
| Sep 30, 2025 | 796,000.00 |
| Jun 30, 2025 | 768,000.00 |
| Mar 31, 2025 | 740,000.00 |
| Dec 31, 2024 | 714,000.00 |
| Sep 30, 2024 | 688,000.00 |
| Jun 30, 2024 | 701,000.00 |
| Mar 31, 2024 | 731,000.00 |
| Dec 31, 2023 | 759,000.00 |
| Sep 30, 2023 | 787,000.00 |
| Jun 30, 2023 | 776,000.00 |
| Mar 31, 2023 | 773,000.00 |
| Dec 31, 2022 | 745,000.00 |
| Dec 31, 2021 | 500,000.00 |